Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Baraa K. Manasrah"'
Autor:
Mark E. Burkard, Ning Jin, David J. Beebe, Beth A. Weaver, Lee G. Wilke, Ruth M. O'Regan, Amye J. Tevaarwerk, Kari B. Wisinski, Mouhita Humayun, Rachel E. Yan, Christina M. Scribano, John B. Tucker, Roshan X. Norman, Robert F. Lera, Stephanie M. McGregor, Baraa K. Manasrah, Yang Hu
Multinucleated H2B-RFP Tub-GFP MDA-MB-231 Multipolar Division
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10cde5cfaa91872e322c4a8409bc24b3
https://doi.org/10.1158/1535-7163.22522734.v1
https://doi.org/10.1158/1535-7163.22522734.v1
Autor:
Mark E. Burkard, Ning Jin, David J. Beebe, Beth A. Weaver, Lee G. Wilke, Ruth M. O'Regan, Amye J. Tevaarwerk, Kari B. Wisinski, Mouhita Humayun, Rachel E. Yan, Christina M. Scribano, John B. Tucker, Roshan X. Norman, Robert F. Lera, Stephanie M. McGregor, Baraa K. Manasrah, Yang Hu
Mononucleated H2B-RFP Tub-GFP MDA-MB-231 Bipolar Division
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cb7ae04f6851d34fc80c9ea3ad040bc
https://doi.org/10.1158/1535-7163.22522740.v1
https://doi.org/10.1158/1535-7163.22522740.v1
Autor:
Christina M. Scribano, Yang Hu, Baraa K. Manasrah, Mouhita Humayun, Roshan X. Norman, Lee G. Wilke, Stephanie M. McGregor, John B. Tucker, Rachel E. Yan, Beth A. Weaver, Ruth O'Regan, Amye J. Tevaarwerk, Ning Jin, Mark E. Burkard, David J. Beebe, Kari B. Wisinski, Robert F. Lera
Publikováno v:
Mol Cancer Ther
Taxanes remain one of the most effective medical treatments for breast cancer. Clinical trials have coupled taxanes with immune checkpoint inhibitors in patients with triple-negative breast cancer (TNBC) with promising results. However, the mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9aad8871e07fab4b6876c1cc4e76cc
https://pubmed.ncbi.nlm.nih.gov/34583980
https://pubmed.ncbi.nlm.nih.gov/34583980
Autor:
John B. Tucker, Baraa K. Manasrah, Beth A. Weaver, Stephanie M. McGregor, Rachel E. Yan, Christina M. Scribano, Mark E. Burkard, Robert F. Lera, Ning Jin, Yang Hu
Publikováno v:
Cancer Research. 80:2248-2248
Introduction: Paclitaxel (TaxolTM) is a blockbuster chemotherapy used for solid tumors including breast cancer. In triple-negative breast cancer (TNBC), nab-paclitaxel plus PD-L1 inhibitor, atezolizumab, is now approved based on increased survival co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::131489af387124bfba9a46a17b68cd34
https://doi.org/10.1158/1538-7445.am2020-2248
https://doi.org/10.1158/1538-7445.am2020-2248